Otros idiomas AFT Pharmaceuticals Limited

Acciones

Precio de cierre New Zealand S.E. Otros sitios de cotización 00:00:00 03/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3 ^NZD	0,00 %		-2,28 %	-14,29 %

01/05	AFT Pharmaceuticals firma un acuerdo de licencia en Brasil para Maxigesic IV	MT
24/04	Las acciones neozelandesas suben tras el repunte de los beneficios en EE.UU.; AFT Pharmaceuticals desarrollará un tratamiento tópico para las cicatrices	MT

AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV	01/05
New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment	24/04
AFT Pharmaceuticals, Massey Ventures, Gillies McIndoe Research Institute Partner to Develop Topical Scar Treatment	24/04
New Zealand Shares Close Flat on Monday; Fletcher Building Chair Steps Down	04/03
AFT Pharmaceuticals to Expand Global Footprint with Signing of Supply, Production Deals	04/03
Aft Expands Its Co-Operation with Hikma Pharmaceuticals	03/03
New Zealand Shares Rebound on Friday Close; AFT Pharmaceuticals Raises Operation Profit Guidance	16/02
AFT Pharmaceuticals Boosts Operating Profit Guidance for Fiscal Year 2024	16/02
AFT Pharmaceuticals Limited Updates Earnings Guidance for the Fiscal Year 2024	15/02
AFT Pharmaceuticals' Licensee Launches Pain Relief Medication in US; Shares Rise 4%	07/02
AFT Pharmaceuticals’ Maxigesic IV Launches in the US	06/02
Rentevrees zet Bel20 onder druk	20/01
KBC uitblinker op groene beurs	19/01
Brusselse beurs opent flink hoger	19/01
Brussel start handelsdag vermoedelijk in het groen	19/01
AFT Pharmaceuticals Ties Up with Belgian Firm to Develop Skin Medication	19/01
Hyloris gaat samenwerken met AFT Pharmaceuticals	18/01
Hyloris Pharmaceuticals SA Enters into Partnership with AFT Pharmaceuticals to Develop a Novel Mucoadhesive Film for the Treatment of Vulvar Lichen Sclerosus	18/01
Bel20 vindt steun in opleving Argenx	22/12
Winst in Brussel dankzij Argenx	22/12

No hay resultados para esta búsqueda